$PSNL
Personalis, Inc.

2023 Q2 Form 10-Q Financial Statement

#000095017023017182 Filed on May 03, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $16.70M $18.86M $15.23M
YoY Change -8.45% 23.86% -27.08%
Cost Of Revenue $11.91M $14.13M $10.95M
YoY Change -14.7% 29.05% -18.62%
Gross Profit $4.792M $4.730M $4.278M
YoY Change 11.94% 10.57% -42.4%
Gross Profit Margin 28.7% 25.08% 28.09%
Selling, General & Admin $12.13M $14.10M $15.49M
YoY Change -23.56% -8.97% 48.6%
% of Gross Profit 253.21% 298.03% 361.99%
Research & Development $17.85M $16.57M $17.10M
YoY Change 9.6% -3.07% 80.05%
% of Gross Profit 372.54% 350.38% 399.67%
Depreciation & Amortization $2.800M $2.800M $1.800M
YoY Change 55.56% 55.56% 20.0%
% of Gross Profit 58.43% 59.2% 42.08%
Operating Expenses $29.99M $30.67M $32.58M
YoY Change -6.77% -5.87% 63.6%
Operating Profit -$25.35M -$29.83M -$28.31M
YoY Change -9.09% 5.37% 126.63%
Interest Expense $39.00K $47.00K $85.00K
YoY Change -22.0% -44.71% -15.0%
% of Operating Profit
Other Income/Expense, Net $1.000K -$26.00K $19.00K
YoY Change -98.0% -236.84% -290.0%
Pretax Income -$23.92M -$28.65M -$28.20M
YoY Change -13.12% 1.57% 127.25%
Income Tax $36.00K $14.00K $7.000K
% Of Pretax Income
Net Earnings -$23.96M -$28.66M -$28.21M
YoY Change -13.04% 1.6% 127.42%
Net Earnings / Revenue -143.45% -151.96% -185.26%
Basic Earnings Per Share -$0.50 -$0.61 -$0.63
Diluted Earnings Per Share -$0.50 -$0.61 -$626.9K
COMMON SHARES
Basic Shares Outstanding 46.78M 46.74M 44.95M
Diluted Shares Outstanding 47.67M 46.74M 45.00M

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $137.2M $148.9M $266.5M
YoY Change -41.24% -44.12% -24.58%
Cash & Equivalents $97.20M $87.17M $91.59M
Short-Term Investments $40.01M $61.77M $175.0M
Other Short-Term Assets $5.476M $7.511M $5.904M
YoY Change -5.39% 27.22% -35.83%
Inventory $8.140M $8.219M $8.065M
Prepaid Expenses
Receivables $10.13M $18.10M $13.52M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $161.0M $182.8M $294.0M
YoY Change -38.1% -37.84% -21.11%
LONG-TERM ASSETS
Property, Plant & Equipment $59.49M $61.45M $82.33M
YoY Change 25.01% -25.36% 290.18%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.937M $3.991M $4.292M
YoY Change -11.31% -7.01% 138.44%
Total Long-Term Assets $88.08M $89.41M $86.62M
YoY Change -10.06% 3.22% 279.91%
TOTAL ASSETS
Total Short-Term Assets $161.0M $182.8M $294.0M
Total Long-Term Assets $88.08M $89.41M $86.62M
Total Assets $249.0M $272.2M $380.6M
YoY Change -30.43% -28.5% -3.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.847M $10.93M $12.28M
YoY Change -58.65% -10.98% 88.85%
Accrued Expenses $789.0K $1.018M $3.212M
YoY Change -83.28% -68.31% 383.01%
Deferred Revenue $3.337M $2.563M
YoY Change 837.36%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $430.0K $2.257M $1.836M
YoY Change -75.36% 22.93%
Total Short-Term Liabilities $28.59M $34.14M $39.84M
YoY Change -31.11% -14.31% 3.22%
LONG-TERM LIABILITIES
Long-Term Debt $395.0K $386.0K $1.716M
YoY Change -77.51%
Other Long-Term Liabilities $4.034M $4.096M $52.37M
YoY Change 80580.0% -92.18% 516.14%
Total Long-Term Liabilities $4.034M $4.096M $54.09M
YoY Change 80580.0% -92.43% 536.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $28.59M $34.14M $39.84M
Total Long-Term Liabilities $4.034M $4.096M $54.09M
Total Liabilities $72.95M $78.55M $93.93M
YoY Change -21.85% -16.38% 99.43%
SHAREHOLDERS EQUITY
Retained Earnings -$413.0M -$389.1M
YoY Change 36.38%
Common Stock $589.4M $583.2M
YoY Change 3.64%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $176.1M $193.6M $286.7M
YoY Change
Total Liabilities & Shareholders Equity $249.0M $272.2M $380.6M
YoY Change -30.43% -28.5% -3.76%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$23.96M -$28.66M -$28.21M
YoY Change -13.04% 1.6% 127.42%
Depreciation, Depletion And Amortization $2.800M $2.800M $1.800M
YoY Change 55.56% 55.56% 20.0%
Cash From Operating Activities -$10.41M -$15.75M -$11.36M
YoY Change -61.92% 38.64% -3.29%
INVESTING ACTIVITIES
Capital Expenditures $2.741M $3.778M -$8.634M
YoY Change -126.59% -143.76% -2066.74%
Acquisitions
YoY Change
Other Investing Activities $22.29M $17.57M $5.473M
YoY Change -33.13% 221.05% -106.67%
Cash From Investing Activities $19.55M $13.79M -$3.161M
YoY Change -15.08% -536.35% -96.17%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 925.0K 0.000 515.0K
YoY Change -320.24% -100.0% -99.68%
NET CHANGE
Cash From Operating Activities -10.41M -15.75M -11.36M
Cash From Investing Activities 19.55M 13.79M -3.161M
Cash From Financing Activities 925.0K 0.000 515.0K
Net Change In Cash 10.06M -1.956M -14.00M
YoY Change -311.88% -86.03% -120.42%
FREE CASH FLOW
Cash From Operating Activities -$10.41M -$15.75M -$11.36M
Capital Expenditures $2.741M $3.778M -$8.634M
Free Cash Flow -$13.16M -$19.52M -$2.723M
YoY Change -22.79% 616.97% -77.65%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001527753
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#AccountsPayableCurrent
CY2022Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#AccountsPayableCurrent
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-38943
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Personalis, Inc.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-5411038
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
6600 Dumbarton Circle
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Fremont
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94555
CY2023Q1 dei City Area Code
CityAreaCode
650
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
752-1300
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001
CY2023Q1 dei Trading Symbol
TradingSymbol
PSNL
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
46783757
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
87172000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
89128000
CY2023Q1 us-gaap Short Term Investments
ShortTermInvestments
61767000
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
78530000
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
18103000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
16642000
CY2023Q1 psnl Inventory And Other Deferred Costs
InventoryAndOtherDeferredCosts
8219000
CY2022Q4 psnl Inventory And Other Deferred Costs
InventoryAndOtherDeferredCosts
8591000
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7511000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6808000
CY2023Q1 us-gaap Assets Current
AssetsCurrent
182772000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
199699000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
61446000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
61935000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
23971000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
26480000
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3991000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4586000
CY2023Q1 us-gaap Assets
Assets
272180000
CY2022Q4 us-gaap Assets
Assets
292700000
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
10927000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
12854000
CY2023Q1 psnl Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
20653000
CY2022Q4 psnl Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
19013000
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2563000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1264000
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
34143000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
33131000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
40309000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
41041000
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4096000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
389000
CY2023Q1 us-gaap Liabilities
Liabilities
78548000
CY2022Q4 us-gaap Liabilities
Liabilities
74561000
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
46774490
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
46774490
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
46707084
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
46707084
CY2023Q1 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
5000
CY2022Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
5000
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
583151000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
579456000
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-455000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-912000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-389069000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-360410000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
193632000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
218139000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
272180000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
292700000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18860000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15227000
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
14130000
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
10949000
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16573000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17098000
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
14097000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15486000
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
3885000
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
48685000
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
43533000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-29825000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-28306000
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
1253000
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
144000
CY2023Q1 us-gaap Interest Expense
InterestExpense
47000
CY2022Q1 us-gaap Interest Expense
InterestExpense
59000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-26000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
19000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-28645000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-28202000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-28659000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-28209000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.61
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.61
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.63
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.63
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46740270
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46740270
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44995752
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44995752
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-28659000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-28209000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
28000
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8000
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
429000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-701000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-28202000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-28918000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
218139000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3695000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
28000
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
429000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-28659000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
193632000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
310301000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
516000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4816000
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-701000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-28209000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
286715000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-28659000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-28209000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3695000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4816000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2781000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1774000
CY2023Q1 psnl Noncash Lease Expense
NoncashLeaseExpense
539000
CY2022Q1 psnl Noncash Lease Expense
NoncashLeaseExpense
2096000
CY2023Q1 psnl Amortization Of Premium Discount On Short Term Investments
AmortizationOfPremiumDiscountOnShortTermInvestments
390000
CY2022Q1 psnl Amortization Of Premium Discount On Short Term Investments
AmortizationOfPremiumDiscountOnShortTermInvestments
-347000
CY2023Q1 psnl Restructuring And Other Charges
RestructuringAndOtherCharges
1204000
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-144000
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-43000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1460000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4949000
CY2023Q1 psnl Increase Decrease In Inventories And Other Deferred Costs
IncreaseDecreaseInInventoriesAndOtherDeferredCosts
-262000
CY2022Q1 psnl Increase Decrease In Inventories And Other Deferred Costs
IncreaseDecreaseInInventoriesAndOtherDeferredCosts
2455000
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
254000
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1720000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1407000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1132000
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
426000
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
3398000
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
4999000
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-522000
CY2023Q1 psnl Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
2375000
CY2022Q1 psnl Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-24000
CY2022Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-422000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15745000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11357000
CY2023Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
21529000
CY2022Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
59702000
CY2023Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
39100000
CY2022Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
65175000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3778000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8634000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
13793000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3161000
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
515000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
515000
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-4000
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1956000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-13999000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
90918000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
107375000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
88962000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
93376000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
87172000
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
91586000
CY2023Q1 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
1790000
CY2022Q1 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
1790000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
88962000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
93376000
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Arial&quot;, sans-serif;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities, at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The estimates include, but are not limited to, useful lives assigned to long-lived assets, discount rates for lease accounting, the valuation of stock options, the valuation of stock-based awards, and provisions for income taxes and contingencies. Actual results could differ from these estimates, and such differences could be material to the Company’s consolidated financial position and results of operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </span></p>
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
40309000
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18860000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15227000
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
6300000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1300000
CY2023Q1 psnl Revenue Performance Obligation Unsatisfied Service Period Description
RevenuePerformanceObligationUnsatisfiedServicePeriodDescription
unsatisfied services under contracts with an original expected duration of more than one year
CY2023Q1 psnl Contract With Customer Unsatisfied Services Revenue
ContractWithCustomerUnsatisfiedServicesRevenue
5000000
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1300000
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2022Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2500000
CY2023Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
5517000
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
6384000
CY2023Q1 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
2702000
CY2022Q4 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
2207000
CY2023Q1 psnl Inventory And Other Deferred Costs
InventoryAndOtherDeferredCosts
8219000
CY2022Q4 psnl Inventory And Other Deferred Costs
InventoryAndOtherDeferredCosts
8591000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2800000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1800000
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
29600000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
26900000
CY2023Q1 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
1800000
CY2022Q4 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
1800000
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9675000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9008000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6529000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5391000
CY2023Q1 us-gaap Loans Payable Current
LoansPayableCurrent
2257000
CY2022Q4 us-gaap Loans Payable Current
LoansPayableCurrent
2218000
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1018000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1700000
CY2023Q1 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
1010000
CY2022Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
543000
CY2023Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
134000
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
123000
CY2023Q1 psnl Contract With Customer Deposits Current
ContractWithCustomerDepositsCurrent
30000
CY2022Q4 psnl Contract With Customer Deposits Current
ContractWithCustomerDepositsCurrent
30000
CY2023Q1 psnl Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
20653000
CY2022Q4 psnl Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
19013000
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
0
CY2023Q1 psnl Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
48013000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
82980000
CY2023Q1 psnl Lessee Operating Lease Liability Discount On Obligation Amount
LesseeOperatingLeaseLiabilityDiscountOnObligationAmount
36142000
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
46838000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6529000
CY2015Q4 us-gaap Land Subject To Ground Leases
LandSubjectToGroundLeases
31280
CY2020 psnl Lease Expiration Month And Year
LeaseExpirationMonthAndYear
2027-11
CY2023Q1 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
an option to extend the term for a period of three years
CY2020 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2020Q4 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P3Y
CY2021Q4 us-gaap Land Subject To Ground Leases
LandSubjectToGroundLeases
14710
CY2021 psnl Lease Expiration Month And Year
LeaseExpirationMonthAndYear
2022-12
CY2021 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
not extended
CY2021 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
false
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
1749000
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
2174000
CY2023Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
99000
CY2022Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
29000
CY2023Q1 us-gaap Variable Lease Cost
VariableLeaseCost
493000
CY2022Q1 us-gaap Variable Lease Cost
VariableLeaseCost
261000
CY2023Q1 us-gaap Lease Cost
LeaseCost
2341000
CY2022Q1 us-gaap Lease Cost
LeaseCost
2464000
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P11Y
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.105
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
4907000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
7895000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
7808000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
7168000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
7189000
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
800000
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
900000
CY2023Q1 psnl Shares Subject To Options And Restricted Stock Or Rsu Awards
SharesSubjectToOptionsAndRestrictedStockOrRSUAwards
9971919
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2748592
CY2023Q1 psnl Shares Of Common Stock Reserved For Future Issuance Under Espp
SharesOfCommonStockReservedForFutureIssuanceUnderESPP
1082950
CY2023Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
13803461
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.91
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.59
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
11600000
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y7M6D
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y9M7D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7898
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.6837
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.6910
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0358
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0162
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0213
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3695000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4816000
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3695000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4816000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-28659000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-28209000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46740270
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46740270
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44995752
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44995752
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.61
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.61
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.63
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.63
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10425299
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6865767
CY2023Q1 us-gaap Restructuring And Related Cost Number Of Positions Eliminated
RestructuringAndRelatedCostNumberOfPositionsEliminated
100
CY2023Q1 us-gaap Restructuring And Related Activities Completion Date
RestructuringAndRelatedActivitiesCompletionDate
2023-03-31
CY2023Q1 psnl Restructuring Expenses Unpaid
RestructuringExpensesUnpaid
800000
CY2023Q1 psnl Restructuring Expenses Related To Disposals Of Fixed Assets And Impairment Of Other Assets
RestructuringExpensesRelatedToDisposalsOfFixedAssetsAndImpairmentOfOtherAssets
500000

Files In Submission

Name View Source Status
0000950170-23-017182-index-headers.html Edgar Link pending
0000950170-23-017182-index.html Edgar Link pending
0000950170-23-017182.txt Edgar Link pending
0000950170-23-017182-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img80061036_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
psnl-20230331.htm Edgar Link pending
psnl-20230331.xsd Edgar Link pending
psnl-ex10_1.htm Edgar Link pending
psnl-ex31_1.htm Edgar Link pending
psnl-ex31_2.htm Edgar Link pending
psnl-ex32_1.htm Edgar Link pending
psnl-ex32_2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
psnl-20230331_cal.xml Edgar Link unprocessable
psnl-20230331_def.xml Edgar Link unprocessable
psnl-20230331_lab.xml Edgar Link unprocessable
psnl-20230331_pre.xml Edgar Link unprocessable
psnl-20230331_htm.xml Edgar Link completed
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending